Abbott Laboratories | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
19,657
20,247
20,405
20,853
27,390
30,578
Cost of Goods Sold (COGS) incl. D&A
9,800
9,757
9,445
9,609
14,266
14,755
Gross Income
9,857
10,490
10,960
11,244
13,124
15,823
SG&A Expense
7,711
7,574
8,011
7,995
11,002
11,979
EBIT
-
-
2,949
3,249
2,122
3,844
Unusual Expense
57
346
127
112
362
247
Non Operating Income/Expense
68
35
434
1,519
1,227
100
Interest Expense
47
164
178
304
880
729
Pretax Income
2,041
2,518
3,183
1,413
2,231
2,873
Income Tax
53
797
577
350
1,878
539
Consolidated Net Income
1,970
1,710
2,586
1,056
344
2,319
Net Income
1,970
1,710
2,586
1,056
344
2,319
Net Income After Extraordinaries
1,382
1,147
769
719
220
2,285
Net Income Available to Common
2,558
2,273
2,651
1,377
468
2,353
EPS (Basic)
1.62
1.49
2.92
0.94
0.27
1.33
Basic Shares Outstanding
1,558
1,516
1,496
1,477
1,740
1,758
EPS (Diluted)
1.63
1.49
2.92
0.94
0.27
1.33
Diluted Shares Outstanding
1,574
1,527
1,506
1,483
1,749
1,770
EBITDA
3,865
4,389
4,421
4,602
5,143
7,122
Non-Operating Interest Income
67
77
105
99
124
105
Other After Tax Income (Expense)
18
11
20
7
9
15
About Abbott Laboratories
View Profile
